Name
CLINICAL PARALLEL 1 - Management of HBV in 2025
Date & Time
Wednesday, March 19, 2025, 8:30 AM - 10:00 AM
Speakers
Harry Janssen, Erasmus MC, University Medical Center Rotterdam
Marion Delphin, the francis crick institute
Erin Mann, Migration Health Initiative
Renee-Claude Mercier, Gilead Sci.
Helen Nde, Center for Disease Analysis Foundation
Description
  • Interferon as a Component of HBV Cure in 2024 and 2034  Harry Janssen
  • Oral Presentation: IMMUNE SIGNATURE ASSOCIATED WITH VIRAL SUPPRESSION FOLLOWING NUCLEOS(T)IDE ANOLOGUE TREATMENT IN ADULTS LIVING WITH CHRONIC HBV INFECTION IN SOUTH AFRICA Marion Delphin
  • Oral Presentation: SIMILAR RATES OF BIOCHEMICAL RESPONSE ARE OBSERVED ACROSS VIROLOGIC RESPONSE CATEGORIES OVER 96 WEEKS OF BULEVIRTIDE Renee-Claude Mercier
  • Oral Presentation: FACTORS INFLUENCING HEPATITIS B SPECIALITY CARE REFERRAL AMONG REFUGEES RECENTLY RESETTLED TO THE UNITED STATES Erin Mann
  • Oral Presentation: CHALLENGES AND OPPORTUNITIES FOR REENGAGING DIAGNOSED BUT UNTREATED HBV/HCV-INFECTED INDIVIDUALS IN THE UNITED STATES TO CARE (PRELIMINARY RESULTS FROM A MULTI-CENTER RELINK PROGRAM) Helen Nde
  • Q&A